Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Cost of rinvoq?

See the DrugPatentWatch profile for rinvoq

Rinvoq (upadacitinib) – Cost Overview (U.S.)

What you’ll pay Typical range Notes
Manufacturer list price $2,000 – $3,000 per month The price shown on the drug’s package insert or the FDA’s drug‑labeling database. It’s the “price” that pharmacies list and insurers reference.
Average Wholesale Price (AWP) $2,400 – $2,700 per month The AWP is the price most wholesalers use for discount calculations; insurers often negotiate below this.
Average Sales Price (ASP) $1,700 – $2,400 per month ASP is the price paid by the pharmacy to the manufacturer, after rebates. Insurers usually use ASP or a negotiated “discounted” price.
Typical out‑of‑pocket cost (with insurance) $0 – $350 per month Depends on your deductible, coinsurance, and pharmacy tier. For many commercial plans the copay is $0–$400 per month for the first 3–6 months, then increases to $200–$300 for the remainder of the year.
High‑deductible plan (self‑pay) $1,200 – $1,800 per month After you meet your deductible, you usually pay 20–30 % of the ASP.
Medicaid $0–$50 per month Medicaid pays the bulk of the drug cost; you may pay a small copay.
Medicare Part D $0–$300 per month Depends on the Part D plan’s formulary tier and your deductible.

Bottom line – The brand name price is roughly $2,000–$3,000 a month. Your actual out‑of‑pocket cost can be much lower if you have insurance, a low‑cost tier, or a patient‑assistance program.


1. How the price gets lowered

Mechanism How it works
Manufacturer rebates Pfizer gives rebates to insurers, pharmacies, and sometimes direct rebates to patients.
Tier placement If the drug is on a higher tier (Tier 3 or 4), you’ll pay a larger copay or coinsurance.
Formulary negotiations Insurers negotiate “discounted” prices; the negotiated price can be 10–30 % below ASP.
Manufacturer patient assistance Pfizer offers a Rinvoq Patient Assistance Program (PAP) for uninsured or under‑insured patients who meet income thresholds.

2. Patient‑Assistance Program (PAP)

Feature Details
Eligibility U.S. residents with no prescription drug coverage, income ≤ 200 % of the Federal Poverty Level (FPL), and no other drug coverage that would cover Rinvoq.
Application Online form on Pfizer’s website (https://www.pfizer.com/patient‑assistance).
Coverage Up to 12 months of free medication.
Reimbursement Once approved, the pharmacy receives payment directly from Pfizer.

Tip – Even if you have insurance, ask your pharmacy or prescriber about the PAP; some patients get a “full” discount that reduces their copay to zero.


3. Other ways to reduce cost

  1. Check your formulary tier – Some plans place Rinvoq in a lower tier after you meet a deductible; that can drop the copay from $350 to $50–$100.
  2. Ask about “step therapy” – Insurers sometimes require a cheaper medication first. If you’re on step therapy, you might get a cheaper drug for a short period and then switch to Rinvoq when you meet the conditions.
  3. Use a discount card – Some pharmacies (e.g., GoodRx) offer coupons that can shave $50–$100 off the monthly cost for uninsured patients. (But check that the card works with your insurer.)
  4. Consider “pharmacy benefit manager” (PBM) rebates – PBMs sometimes negotiate lower ASPs; ask your pharmacist or insurer about the current PBM discount for Rinvoq.

4. Generic status

  • No generic is currently approved for Rinvoq. The patent remains in force through the 2030s, so the brand price is set until a generic entrant appears (likely 2028‑2030).

5. Quick cost‑check tools

Tool Where to find it What it does
GoodRx https://www.goodrx.com Shows current pharmacy prices and discount coupons for Rinvoq.
RxList “Price Checker” https://www.rxlist.com Lists average cost by pharmacy and state.
Your insurer’s “Cost Estimator” On your insurance portal Lets you enter drug name and see the estimated out‑of‑pocket cost.
Pharmacy’s “Patient Assistance” portal At your local pharmacy Often has a quick screen for eligibility.

6. Practical steps for you

  1. Check your insurance plan – Log in to your insurer’s portal or call the member services number to see whether Rinvoq is on the formulary, its tier, and your current deductible status.
  2. Ask your prescriber – If you’re already on Rinvoq, request a cost‑analysis sheet from the pharmacy; many pharmacists provide a “cost‑comparison” with other drugs.
  3. Apply for the PAP – If you’re uninsured or under‑insured, fill out the form on Pfizer’s site. Even if you have insurance, it might lower your copay or give you a free month.
  4. Talk to your pharmacist – They can often negotiate a lower price, apply a discount card, or direct you to the PAP if you’re eligible.

Bottom line

  • Brand price: ~$2,000–$3,000 per month.
  • Out‑of‑pocket (with insurance): $0–$350/month; can be lower with PAP or lower formulary tier.
  • No generic yet, so brand price will stay until a generic enters the market.

If you have more specific questions (e.g., about Medicaid, Medicare, or a particular insurance plan), let me know, and I can dig into the details!



Other Questions About Rinvoq :

Rinvoq weight gain? Can rinvoq cause weight gain? Is rinvoq safe for patients with a history of blood clots? Is there a generic for rinvoq? How long does rinvoq take to work? How does rinvoq work for ulcerative colitis? Does rinvoq work for rheumatoid arthritis?

AI-Drug Label Prescribing Information Alignment Report

65
65%
Grade C

Partial

Partially Aligned

Patient Risk: Low

Summary

One of three AI claims is supported by the label (active ingredient). The dosing and generic-status claims are not verifiable from the provided label content.


Category Scores

Dosage
82
Good

Accurate Statements

Rinvoq is upadacitinib.
Label DESCRIPTION states 'RINVOQ and RINVOQ LQ are formulated with upadacitinib' (Section 11).

Unsupported Statements

In the United States, typical dosing is 15 mg once daily.
Label excerpt provided does not include explicit dosing information; Section 2 (DOSAGE AND ADMINISTRATION) content is not shown in the prompt.
There is no generic version yet.
Label content provided does not address generic availability; no statement about generics is present in the excerpt.

Contradictions


Important Omissions

Indication (approved uses) and full dosing regimen details from Section 2; safety-related content (boxed warnings, precautions) and other label sections not provided in the prompt.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
Evaluation focuses on label claims without evaluating safety signals.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Partially Aligned

Primary Issue
Dosing assertion not verifiable from the provided label content; generic status not addressed.

Suggested Improvement
Confirm and cite Section 2 (DOSAGE AND ADMINISTRATION) dosing details for the 15 mg daily regimen and verify whether generic versions are discussed in any labeling or regulatory communications.

Drug Brand Mention Assessment

Branding Score
35
Visibility
50
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For


Core Claims
  • the list price for a 30‑day supply is commonly around $7,000–$8,000 before insurance.
  • AbbVie and drug‑assistance programs sometimes offer savings or copay help for commercially insured patients.
  • Important: there’s no generic version yet, so prices are driven by the brand list price and insurance coverage.
  • With insurance or a specialty pharmacy plan, your out‑of‑pocket cost can be much lower, often ranging from $0 to a few hundred dollars per month, depending on your plan, deductible, and formulary placement.
Differentiators

Pricing Perception: Premium